Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/18/2014US8673586 Compounds that interact with kinases
03/18/2014US8673573 Use of eIF3m for the diagnosis and treatment of cancer
03/18/2014US8673366 Chemotherapeutic and prophylactic pharmaceutical compositions
03/18/2014US8673362 Therapeutic stem cell nutrient composition and uses thereof
03/18/2014US8673360 Compositions that enable rapid-acting and highly absorptive intranasal administration
03/18/2014US8673355 Opioid agonist/antagonist combinations
03/18/2014US8673349 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
03/18/2014US8673348 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
03/18/2014US8673347 Polymer conjugates of K-252A and derivatives thereof
03/18/2014US8673346 Transdermal drug delivery method and system
03/18/2014US8673343 Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels and for the prevention and treatment of cancer
03/18/2014US8673340 Sodium channel blocker delivery system with scleral lens
03/18/2014US8673336 Composition, system, and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility
03/18/2014US8673328 Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, stearic acid, magnesium sulfate, zinc oxide, glycerin, and water
03/18/2014US8673322 Crystals of laquinimod sodium, and process for the manufacture thereof
03/18/2014US8673321 Cyclophosphamide in combination with anti-idiotypic vaccines
03/18/2014US8673316 Avirulent, immunogenic flavivirus chimeras
03/18/2014US8673288 Compositions and methods for inhibiting entry of a hepatic virus
03/18/2014US8673287 Anti-obesity composition containing acacia bark derivative
03/18/2014US8673285 Sphingoid polyalkylamine conjugates for vaccination
03/18/2014US8673284 Cosmetic compositions containing block copolymers, tackifiers and a selective solvent for hard blocks
03/18/2014US8673283 Cosmetic compositions containing block copolymers, tackifiers and a solvent mixture
03/18/2014US8673282 Cosmetic compositions containing block copolymers, tackifiers and a selective solvent for soft blocks
03/18/2014US8673281 Pharmaceutical composition for intracellular acidification with cis-urocanic acid
03/18/2014US8673280 Pharmaceutical composition for intracellar acidification with cis-urocanic acid
03/18/2014US8672975 Spine distraction implant and method
03/18/2014US8672974 Spine distraction implant and method
03/18/2014CA2768682C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
03/18/2014CA2767061C Specific binding agents of human angiopoietin-2
03/18/2014CA2749174C Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
03/18/2014CA2746811C Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals
03/18/2014CA2743562C Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
03/18/2014CA2740815C New uses for amino acid anticonvulsants
03/18/2014CA2726147C Caprazene and derivatives thereof
03/18/2014CA2719538C Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
03/18/2014CA2700526C New compounds as adenosine a1 receptor antagonists
03/18/2014CA2682596C Use of carboxyamidotriazole (cai) orotate in macular degeneration
03/18/2014CA2680945C Anti-pdgfralpha antibodies
03/18/2014CA2665075C High-purity large-scale preparation of stannsoporfin
03/18/2014CA2655788C Skin external preparation containing triterpenic acid
03/18/2014CA2649758C Preparation and purification of mupirocin calcium
03/18/2014CA2647677C Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/18/2014CA2637590C Treatment of inflammatory disorders with triazole compounds
03/18/2014CA2632893C (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
03/18/2014CA2629915C Isoquinoline derivatives
03/18/2014CA2626635C Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof
03/18/2014CA2626181C Modulation of trpv expression levels
03/18/2014CA2621182C 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
03/18/2014CA2619898C Diaminopyrimidines as p2x3 and p2x2/3 modulators
03/18/2014CA2619039C 1-acyldihydropyrazole derivatives
03/18/2014CA2614764C Sustained release of antiinfectives
03/18/2014CA2614192C Use of docosahexaenoic glycerides for the treatment of tumoral diseases
03/18/2014CA2608974C Substituted 7,8-dihydro-1h-pyrimido[4,5-b][1,4]diazepin-4-amines are novel kinase inhibitors
03/18/2014CA2605748C Novel specific caspase-10 inhibitors
03/18/2014CA2593084C Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions
03/18/2014CA2592154C N-hydroxyamide derivatives and use thereof
03/18/2014CA2580692C Use of glutamic acid or salts thereof in preventing or improving functional digestive disorder
03/18/2014CA2576275C Multiparticulates with controlled release properties and free of lubricant
03/18/2014CA2567808C Therapy of platinum-resistant cancer
03/18/2014CA2564737C Contrast agents for myocardial perfusion imaging
03/18/2014CA2513936C Compositions and methods for treating skin conditions
03/18/2014CA2469588C Highly concentrated stable meloxicam solutions for needleless injection
03/18/2014CA2405238C Single-dose antihistamine/decongestant formulations for treating rhinitis
03/18/2014CA2375633C Cranberry seed oil extract and compositions containing components thereof
03/17/2014DE202013001998U1 Katheter, insbesondere zur Behandlung von Prostata und/oder Blase, und diesen Katheter enthaltendes Kit Catheter, in particular for the treatment of prostate and / or bladder, and this catheter kit containing
03/13/2014WO2014040087A1 A virucidal small molecule and uses thereof
03/13/2014WO2014040077A1 Methods of treating muscular dystrophy
03/13/2014WO2014040073A1 C13-hydroxy derivatives of oleanolic acid and methods of use thereof
03/13/2014WO2014040067A1 Composition of hmb and atp and methods of use
03/13/2014WO2014040060A1 C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
03/13/2014WO2014040056A1 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
03/13/2014WO2014039971A1 Inhibitors of met, vegfr and ret for use in the treatment of lung adenocarcinoma
03/13/2014WO2014039964A2 Compounds and methods for modulating vascular injury
03/13/2014WO2014039960A1 Methods for the treatment of locally advanced breast cancer
03/13/2014WO2014039939A1 Pharmaceutical compositions comprising flurbiprofen
03/13/2014WO2014039920A1 Administration of acetylcholinesterase inhibitors to mitigate neurotoxin-induced paralysis and residual neuromuscular blockade
03/13/2014WO2014039917A1 Benzoquinone derivatives for treating oxidative stress disorders
03/13/2014WO2014039908A1 Methods and compositions for regenerating hair cells and/or supporting cells
03/13/2014WO2014039899A1 Pyrazolopyrimidine compounds as kinase inhibitors
03/13/2014WO2014039862A1 Quinone derivatives for use in the modulation of redox status of individuals
03/13/2014WO2014039860A2 Compositions and methods for modulating dnmt1 inhibitor activity
03/13/2014WO2014039855A1 Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor
03/13/2014WO2014039839A1 Method of treating leukemia
03/13/2014WO2014039831A1 SUBSTITUTED-1,4-DIHYDROPYRAZOLO[4,3-b]INDOLES
03/13/2014WO2014039829A2 Magnetodynamic activation of 13c-acyl isoniazid and isoniazid and ethionamide derivatives
03/13/2014WO2014039820A1 Aldo-keto reductase subfamily 1c3 (akr1c3) inhibitors
03/13/2014WO2014039781A1 Treating hearing loss
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039757A1 Heterocyclic nuclear hormone receptor modulators
03/13/2014WO2014039748A1 Isotopically enriched arylsulfonamide ccr3 antagonists
03/13/2014WO2014039742A1 Combination treatments for melanoma
03/13/2014WO2014039741A2 Treatments for melanoma
03/13/2014WO2014039714A2 Compounds and methods for kinase modulation, and indications therefor
03/13/2014WO2014039677A1 Coated pharmaceutical composition containing regorafenib
03/13/2014WO2014039660A1 Methods for producing rejuvenated red blood cells
03/13/2014WO2014039652A1 Methods for producing and using rejuvenated red blood cells
03/13/2014WO2014039627A1 Anticholinergic neuroprotective composition and methods
03/13/2014WO2014039595A1 Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
03/13/2014WO2014039533A2 Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
03/13/2014WO2014039515A2 Antifungal agents and uses thereof
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 7860